Reporting Manager
Framework Ventures IV L.P.
Symbol
NBY
Shares outstanding
125,955,831 shares
Disclosed Ownership
56,806,080 shares
Ownership
45%
Form type
SCHEDULE 13D/A
Filing time
20 Oct 2025, 21:42:03 UTC
Date of event
16 Oct 2025
Previous filing
15 Oct 2025
Next filing
21 Jan 2026

Sponsored

Quoteable Key Fact

"Framework Ventures IV L.P. disclosed 45% ownership in NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY) on 16 Oct 2025."

Quick Takeaways

  • Framework Ventures IV L.P. filed SCHEDULE 13D/A for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY).
  • Disclosed ownership: 45%.
  • Date of event: 16 Oct 2025.

What Changed

  • Previous schedule filing date: 15 Oct 2025.
  • Current filing was accepted on 20 Oct 2025, 21:42.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Framework Ventures IV L.P. 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002028474
Framework Ventures Management LLC 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002091751
Framework Ventures IV GP LLC 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002092591
Vance Spencer 45% 56,806,080 0 56,806,080 /s/ Vance Spencer Vance Spencer 0002092030
Michael Ernest Anderson 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson